Organovo Holdings, Inc. announced the hiring of Curtis Tyree, PhD, as Sr. Vice President of Strategy and Business Development. Dr. Tyree has more than 20 years of management and R&D experience in the drug discovery industry in a variety of therapeutic areas at Ligand Pharmaceuticals, TorreyPines Therapeutics (previously Neurogenetics) and most recently served as SVP, Strategic Planning at HUYABIO International.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.99 USD | +4.10% | +8.79% | -10.81% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.81% | 11.28M | |
+29.03% | 49.18B | |
-0.10% | 42.11B | |
+46.85% | 40.37B | |
-5.26% | 28.85B | |
+11.48% | 26.09B | |
-22.74% | 18.71B | |
+9.06% | 13.26B | |
+30.01% | 12.32B | |
-1.51% | 11.99B |
- Stock Market
- Equities
- ONVO Stock
- News Organovo Holdings, Inc.
- Organovo Holdings, Inc. Announces the Hiring of Curtis Tyree, PhD, as Sr. Vice President of Strategy and Business Development